YGFGF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 YGFGF pulled ahead of the other in Year 1
Combined, YGFGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YGFGF + JNJ for your $10,000?
YanGuFang International Group Co., Ltd., through its subsidiaries, engages in the production and sale of whole grain foods in the People's Republic of China. It offers oat germ groats, oatmeal, oat flour, oat bran, and gourmet rice; and grains, including black beans, red beans, corns, and other grains. The company also provides oat nutrient and health products comprising oat peptide series products, dietary fiber powder, oat ß-glucan probiotics, oat biscuits, flaxseed oil, and perilla seed oil series products, as well as oat daily necessity products, such as oat toothpaste, oat face mask, oat face cleanser, oat hand soap, and hand cream products. In addition, it offers technology consulting and service. The company sells its products through its own sales team and distribution network, as well as offline and online channels. YanGuFang International Group Co., Ltd. was incorporated in 2020 and is headquartered in Shanghai, the People's Republic of China.
Full YGFGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.